Saint Laurent du Var, France

Eric Duranti

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Laboratoire Theramex, Laboratoire Thermamex. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Duranti. Retrieved from https://idiyas.com/inventor/eric-duranti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric Duranti

Introduction

Eric Duranti is a notable inventor based in Saint Laurent du Var, France. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on the development of novel compounds with potential therapeutic applications.

Latest Patents

Among his latest patents, one notable invention is related to 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them. This invention pertains to compounds of a specific formula, which are detailed in the specification. Another significant patent involves indazoles, benzisoxazoles, and benzisothiazoles, which are recognized for their use as estrogenic agents. These compounds are also defined by a specific formula and serve as modulators of estrogen receptors.

Career Highlights

Throughout his career, Eric Duranti has worked with reputable companies, including Laboratoire Thermamex and Laboratoire Theramex. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Eric has collaborated with several professionals in his field, including Jean Lafay and Paule Bonnet. These partnerships have likely enhanced his research and development efforts.

Conclusion

Eric Duranti's innovative work in pharmaceuticals, particularly in the development of estrogenic agents and related compounds, showcases his valuable contributions to the industry. His patents reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…